ResMed Inc. (OTCMKTS:RSMDF) Files An 8-K Results of Operations and Financial Condition
Disclosure of Results of Operations and Financial
On April27, 2017 we issued the press release attached as Exhibit
99.1. It is incorporated into this report by reference. The press
release describes the results of our operations for the quarter
ended March31, 2017.
On April27, 2017, we announced that our board of directors
declared a quarterly cash dividend of US $0.33 per share. The
dividend will have a record date of May11, 2017, payable on
June15, 2017. The dividend will be paid in U.S. currency to
holders of ResMeds common stock trading on the New York Stock
Exchange. Holders of Chess Depositary Instruments trading on the
Australian Securities Exchange will receive an equivalent amount
in Australian currency, based on the exchange rate on the record
date, and reflecting the 10:1 ratio between CDIs and NYSE shares.
The ex-dividend date will be May10, 2017 for common stock holders
and for CDI holders. ResMed has received a waiver from the ASXs
settlement operating rules, which will allow ResMed to defer
processing conversions between its common stock and CDI registers
from May10, 2017 through May11, 2017 inclusive.
|Item9.01.||Financial Statements and Exhibits.|
Description of Document
Press Release dated April27, 2017 regarding results of
We have authorized the person whose
ResMed Inc. (OTCMKTS:RSMDF) Recent Trading Information
ResMed Inc. (OTCMKTS:RSMDF) closed its last trading session 00.00 at 7.06 with 1,000 shares trading hands.